AbCellera Enters Pact with Kodiak Sciences to Develop Eye Disease Antibodies
AbCellera and Kodiak Sciences announced a new partnership to create and develop therapeutic antibodies for ophthalmologic indications.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
Bellicum Slashes 79% of Workforce in Restructuring
/in Business, CAR-T Therapy, Clinical Trials, Job Cuts, R&D, Restructuring, SharesShares of Bellicum Pharmaceuticals plunged following an announcement that the company will slash 79% of employees as part of a restructuring following the developmental pause for one CAR-T program.
Regeneron to stop enrolling very sick Covid-19 patients in antibody trials
/in Hospitalized COVID-19 PatientsRegeneron Pharmaceuticals will stop enrolling patients receiving advanced Covid-19 care in a trial testing the company’s experimental antibody treatment in hospitalized patients, based on the recommendation of an independent safety board.
Walmart unit Sam’s Club partners with DoorDash to deliver medicines
/in Coronavirus Disease (COVID-19) Pandemic, WalmartWalmart Inc. unit Sam’s Club said the warehouse chain will provide prescribed medicines to patients through delivery firm DoorDash Inc., as customers turn to digital orders during the Covid-19 pandemic.
With election looming, U.S. faces record surge of coronavirus cases
/in Coronavirus Cases, United StatesA record surge of coronavirus cases in the United States is pushing hospitals to the brink of capacity and killing up to 1,000 people a day, the latest figures show, with much of the country’s attention focused on the 2020 presidential election.
AstraZeneca sells commercial rights to two drugs in $400 million deal
/in Blood Pressure, Heart FailureAstraZeneca Plc will sell commercial rights for two products to a German pharmaceutical company for $400 million as the British drugmaker looks to focus on newer medicines in new therapy areas.
Syneos Health to Acquire CRO Synteract
/in Acquisitions, Biopharmaceutical, Business, Contract Research Organization (CRO), Cost Synergies, Dermatology, Neuroscience, Oncology, Orphan Diseases, Pediatrics, Rare DiseasesSyneos Health announced an agreement to acquire Synteract, a full-service contract research organization (CRO) focused on the biopharmaceutical industry.
Novartis sickle cell medicine Adakveo approved in Europe to prevent recurrent VOCs
/in Issue ArchivesThe European Commission approved Novartis’ Adakveo (crizanlizumab) for the prevention of recurrent vaso-occlusive crises (VOCs), or pain crises, in patients with sickle cell disease aged 16 years and older.
Task force sees ‘unrelenting’ Covid-19 spread; daily U.S. cases up by record 91,000
/in Arizona, CNN, Donald Trump, Dr. Anthony Fauci (Director), Elections, Hospitalized COVID-19 Patients, Joe Biden, Midwest, Mike DeWine (Ohio), National Institute of Allergy and Infectious Diseases (NIAID), Temperature, Utah, West, White House coronavirus task forceThe White House coronavirus task force warned that much of the country is in the grips of an “unrelenting” surge in Covid-19 cases and urged tough countermeasures, as the reported number of U.S. infections hit a new daily record of more than 91,000.
Pharma Companies Strike Deals to Deliver Millions of Covid-19 Vaccines by 2021
/in "Operation Warp Speed" Initiative, AstraZeneca, Biomedical Advanced Research and Development Authority (BARDA), Business, Clinical Trials, COVID-19 Vaccines, Deals, GlaxoSmithKline, Immune Response, Johnson & Johnson, Manufacturing, Moderna, Novavax, Pfizer, Pharma Companies, R&D, SanofiLeading pharmaceutical companies – including Moderna, Pfizer and AstraZeneca – are racing ahead to develop and distribute a Covid-19 vaccine.